PROVITA NUTRITION AND HEALTH INC · 99-39 · CANADA
For PROVITA NUTRITION AND HEALTH INC · 99-39 · CANADA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is CANADA; product is Prostate Pro Dietary Supplements Capsules | Nervine Herbal Supplement Capsules | Prostate Pro Dietary Supplements Capsules | Prostate Pro Dietary Supplements Capsules | Nervine Herbal Supplement Capsules | Prostate Pro Dietary Supplements Capsules | Nervine Herbal Supplement Capsules | Prostate Pro Dietary Supplements Capsules | Nervine Herbal Supplement Capsules; product code is 54 E - - 91 Boswellia (Herbal & Botanical Teas) | 54 F - - 50 Hawthorn (Herbal & Botanicals, not Teas) | 54 F - - 58 Saw Palmetto (Herbal & Botanicals, not Teas) | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 04/18/2023; address is 1102-1225 Kingsway Ave , Port Coquitlam, British Columbia CANADA, verified against its source on 2026-09-16.
- Firm
- PROVITA NUTRITION AND HEALTH INC verified
- Import alert
- 99-39
- Import alert name
- Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- Country
- CANADA verified
- Address
- 1102-1225 Kingsway Ave , Port Coquitlam, British Columbia CANADA verified
- Date published
- 04/18/2023 verified
- Product code
- 54 E - - 91 Boswellia (Herbal & Botanical Teas) | 54 F - - 50 Hawthorn (Herbal & Botanicals, not Teas) | 54 F - - 58 Saw Palmetto (Herbal & Botanicals, not Teas) | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Prostate Pro Dietary Supplements Capsules | Nervine Herbal Supplement Capsules | Prostate Pro Dietary Supplements Capsules | Prostate Pro Dietary Supplements Capsules | Nervine Herbal Supplement Capsules | Prostate Pro Dietary Supplements Capsules | Nervine Herbal Supplement Capsules | Prostate Pro Dietary Supplements Capsules | Nervine Herbal Supplement Capsules each item verified
- FDA notes
- The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of section 403(q)(5)(F) of the Act (21 U.S.C. 343 (q)(5)(F)), in that the presentation of the nutrition information on the labeling of your product does not comply with 21 CFR 101.36. In that the article appears to be misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. § 343 (s)(2)(C)], in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). In that it appears appear to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of section 403(q)(5)(F) of the Act (21 U.S.C. 343 (q)(5)(F)), in that the presentation of the nutrition information on the labeling of your product does not comply with 21 CFR 101.36. In that the article appears to be misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. § 343 (s)(2)(C)], in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). In that it appears appear to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of section 403(q)(5)(F) of the Act (21 U.S.C. 343 (q)(5)(F)), in that the presentation of the nutrition information on the labeling of your product does not comply with 21 CFR 101.36. In that the article appears to be misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. § 343 (s)(2)(C)], in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). In that it appears appear to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of section 403(q)(5)(F) of the Act (21 U.S.C. 343 (q)(5)(F)), in that the presentation of the nutrition information on the labeling of your product does not comply with 21 CFR 101.36. In that the article appears to be misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. § 343 (s)(2)(C)], in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). In that it appears appear to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of section 403(q)(5)(F) of the Act (21 U.S.C. 343 (q)(5)(F)), in that the presentation of the nutrition information on the labeling of your product does not comply with 21 CFR 101.36. In that the article appears to be misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. § 343 (s)(2)(C)], in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). In that it appears appear to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. each item verified
What the source says
PROVITA NUTRITION AND HEALTH INC Date Published : 04/18/2023 1102-1225 Kingsway Ave , Port Coquitlam, British Columbia CANADA 54 E - - 91 Boswellia (Herbal & Botanical Teas) Date Published: 04/18/2023 Desc: Prostate Pro Dietary Supplements Capsules Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of section 403(q)(5)(F) of the Act (21 U.S.C. 343 (q)(5)(F)), in that the presentation of the nutrition information on the labeling of your product does not comply with 21 CFR 101.36. In that the article appears to be misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. § 343 (s)(2)(C)], in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). In that it appears appear to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. 54 F - - 50 Hawthorn (Herbal & Botanicals, not Teas) Date Published: 04/18/2023 Desc: Nervine Herbal Supplement Capsules Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. 54 F - - 58 Saw Palmetto (Herbal & Botanicals, not Teas) Date Published: 04/18/2023 Desc: Prostate Pro Dietary Supplements Capsules Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of section 403(q)(5)(F) of the Act (21 U.S.C. 343 (q)(5)(F)), in that the presentation of the nutrition information on the labeling of your product does not comply with 21 CFR 101.36. In that the article appears to be misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. § 343 (s)(2)(C)], in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). In that it appears appear to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 04/18/2023 Desc: Prostate Pro Dietary Supplements Capsules Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of section 403(q)(5)(F) of the Act (21 U.S.C. 343 (q)(5)(F)), in that the presentation of the nutrition information on the labeling of your product does not comply with 21 CFR 101.36. In that the article appears to be misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. § 343 (s)(2)(C)], in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). In that it appears appear to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 04/18/2023 Desc: Nervine Herbal Supplement Capsules Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 04/18/2023 Desc: Prostate Pro Dietary Supplements Capsules Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of section 403(q)(5)(F) of the Act (21 U.S.C. 343 (q)(5)(F)), in that the presentation of the nutrition information on the labeling of your product does not comply with 21 CFR 101.36. In that the article appears to be misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. § 343 (s)(2)(C)], in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). In that it appears appear to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 04/18/2023 Desc: Nervine Herbal Supplement Capsules Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 04/18/2023 Desc: Prostate Pro Dietary Supplements Capsules Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of section 403(q)(5)(F) of the Act (21 U.S.C. 343 (q)(5)(F)), in that the presentation of the nutrition information on the labeling of your product does not comply with 21 CFR 101.36. In that the article appears to be misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. § 343 (s)(2)(C)], in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). In that it appears appear to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 04/18/2023 Desc: Nervine Herbal Supplement Capsules Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3): In that it appears to be misbranded within the meaning of Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)], in that the label fails to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. In that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C. §343(y)], in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_1144.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.